A presentation to: Meeting name Date

Slides:



Advertisements
Similar presentations
Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women: a Cochrane review Clinical.
Advertisements

0 Glaucoma can take your sight away. Keep Vision in Your Future.
Will my Glaucoma patient lose vision ?
TARIQ ALASBALI WHICH PATIENTS ARE AT RISK FOR THE PROGRESSION?
The AMBER study Abdominal Massage for Neurogenic Bowel Dysfunction in People with Multiple Sclerosis Background Objective Study Design and AMBER Study.
Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.
Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity.
Vaccines for preventing influenza in healthy adults: a Cochrane review Clinical
Thrombolysis for acute ischaemic stroke Clinical
To establish whether a difference in SBP between arms is associated with peripheral or cardiovascular (CV) disease, and with an increased risk of CV or.
Webinar May 25th METHYLPHENIDATE FOR CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Hot topics in smoking cessation Robert West University College robertjwest 1.
iStent with phacoemulsification, n=50
The effects of Nd:YAG (neodymium: yttrium-aluminum-garnet) laser peripheral iridotomy (PI) on contra-lateral eye anterior chamber parameters of patients.
The Efficacy and Safety of the Low Intensity Ultrasound Treatment in Patients with Open Angle Glaucoma Hyoung Won Bae, Gong Je Seong, Chan Yun Kim Institute.
Tulsi Changulani 1,*, Jenny Bo 2, Mei-Ling Cheng 1, Andrew Tatham 1
Safety of medication reduction for Primary Angle Closure (PAC) –
Review of Glaucoma Suspect
Neuroretinal Rim Recovery In Narrow Angle Glaucoma After Intraocular Pressure Lowering With Topical Medications  – Case Report Božić M.1,2, Marković V.
A NEW INTRACANALICULAR DEVICE TO TREAT OPEN-ANGLE GLAUCOMA
Lasers in Glaucoma: Meta analysis
From: Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure
A presentation to: Meeting name Date
Ian Saldanha, MBBS, MPH, PhD
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Preoperative Characteristics
By: Jane Barlow, Esther Coren, Sarah Stewart-Brown
Glaucoma.
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Kyoto Prefectural University of Medicine
Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES study Jelena Savović1, Becky Turner2, David.
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
List of Methodological Limitations (Pollock, 2017)
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Cheil Eye Hospital , Daegu, Korea
pulmonary embolism protocol -- EMB review
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Ophthalmology Glaucoma
Micropulse Transscleral Cyclophotocoagulation
Surgical Peripheral Iridectomy In Implantable Collamer Lens Procedure
Presentation transcript:

A presentation to: Meeting name Date Peripheral iridotomy for pigmentary glaucoma Manuele Michelessi, Kristina Lindsley Issue 2, 2016 A presentation to: Meeting name Date

Table of Contents 01 Background 02 Types of studies 03 Key results 04 Tables (Risk of Bias/Forest Plots) 05 Conclusions 06 Acknowledgements

01: Background Pigmentary glaucoma, in eyes with pigment dispersion syndrome, is typically treated with topical medication Peripheral laser iridotomy may alleviate intraocular pressure, stopping or slowing pigment dispersion Objective: To assess the effects of peripheral laser iridotomy compared with other interventions.

02: Types of studies Participants Five randomized controlled trials, 260 eyes of 195 participants Interventions Yttrium-aluminium-garnet (YAG) laser iridotomy versus no laser iridotomy

03: Key results “…the risk of progression of visual field damage was uncertain when comparing laser iridotomy with no iridotomy” RR 1.00, 95% CI 0.16 to 6.25 “At three-year follow-up, one trial reported that the risk ratio for conversion to glaucoma was 2.72 (95% CI 0.76 to 9.68; 42 eyes).”

03: Key results (continued) “At an average of nine months of follow-up, the mean difference in IOP between groups was 2.69 mmHg less in the laser iridotomy group than in the control group (95% CI -6.05 to 0.67; 14 eyes) ”

04: Tables

05: Conclusions “We found insufficient evidence of high quality on the effectiveness of peripheral iridotomy for pigmentary glaucoma or pigment dispersion syndrome.”

06: Acknowledgements Cochrane Eyes and Vision US Satellite, funded by the National Eye Institute, National Institutes of Health Cochrane Eyes and Vision Editorial Base, funded by the UK National Health Service Research and Development Programme Manuele Michelessi, Kristina Lindsley Review citation Michelessi M, Lindsley K. Peripheral iridotomy for pigmentary glaucoma. Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No.: CD005655. DOI: 10.1002/14651858.CD005655.pub2